PCK2 and neoplasm: Thus, the diversity of PCK2 expression in different cancer models make it a challenging therapeutic target and it is required to fully investigate the underlying molecular mechanisms of PCK2-mediated tumor development in different tissues and disease stages (Yu et al., 2023).